BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strüder D, Momper T, Irmscher N, Krause M, Liese J, Schraven S, Zimpfer A, Zonnur S, Burmeister AS, Schneider B, Frerich B, Mlynski R, Große-Thie C, Junghanss C, Maletzki C. Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies. J Exp Clin Cancer Res 2021;40:246. [PMID: 34362423 DOI: 10.1186/s13046-021-02047-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Li Z, Xu Z, Tang Y, Duan C, Dai H, Dai X, Wei X, Liu Y, Xu C, Han B. Reactive oxygen species-based nanotherapeutics for head and neck squamous cell carcinoma. Materials & Design 2022;223:111194. [DOI: 10.1016/j.matdes.2022.111194] [Reference Citation Analysis]
2 Becker A, Zonnur S, Zimpfer A, Krause M, Schneider B, Strueder DF, Burmeister A, Erbersdobler A, Junghanss C, Maletzki C. CMTM6 and PD-L1 are independent prognostic biomarkers in head and neck squamous cell carcinoma.. [DOI: 10.21203/rs.3.rs-2111803/v1] [Reference Citation Analysis]
3 Schoenwaelder N, Krause M, Freitag T, Schneider B, Zonnur S, Zimpfer A, Becker AS, Salewski I, Strüder DF, Lemcke H, Grosse-Thie C, Junghanss C, Maletzki C. Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches. Cancers (Basel) 2022;14:2484. [PMID: 35626088 DOI: 10.3390/cancers14102484] [Reference Citation Analysis]
4 Ursu RG, Luchian I, Damian C, Porumb-andrese E, Ghetu N, Cobzaru RG, Lunca C, Ripa C, Costin D, Jelihovschi I, Petrariu FD, Iancu LS. Diagnostics of HNSCC Patients: An Analysis of Cell Lines and Patient-Derived Xenograft Models for Personalized Therapeutical Medicine. Diagnostics 2022;12:1071. [DOI: 10.3390/diagnostics12051071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Karin N. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Cancers (Basel) 2021;13:6317. [PMID: 34944943 DOI: 10.3390/cancers13246317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]